ZENTALIS PHARMACEUTICALS INC (ZNTL)

US98943L1070 - Common Stock

11.71  +0.6 (+5.4%)

After market: 11.71 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
N/A0.000.000.000.00
Minority Interest Expense
114.00K310.00K7.37M710.00K720.00K
Operating Expenses
299.51M227.29M207.74M118.79M46.85M
Research and Development
235.16M172.73M166.80M84.90M38.39M
Selling, General, and Administrative Expenses
64.35M54.55M40.94M33.89M8.46M
Operating Income
-299.51M-227.29M-207.74M-118.79M-46.85M
Interest Income/Expense
22.62M5.99M400.00K680.00K500.00K
Other Income/Expense
N/AN/AN/AN/A-20.00K
Non Recurring Items
0.000.0042.78MN/AN/A
Income Before Taxes
-276.89M-221.30M-164.56M-118.10M-46.36M
Income Tax
-601.00K-470.00K-300.00K440.00K20.00K
Net Income
-292.19M-236.81M-158.73M-117.84M-45.66M
EBITDA
-298.12M-225.86M-207.20M-118.63M-46.74M
 
Per Share Data
EPS Diluted Total Ops
-4.47-4.48-3.72-4.19-1.32
Non GAAP EPS
-4.64-4.53-4.94-5.58N/A
 
Statistics
Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A

All data in USD

Charts